Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Hereditary Angioedema Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hereditary Angioedema Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hereditary Angioedema Therapeutic Overall Market Size
2.1 Global Hereditary Angioedema Therapeutic Market Size: 2021 VS 2028
2.2 Global Hereditary Angioedema Therapeutic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hereditary Angioedema Therapeutic Players in Global Market
3.2 Top Global Hereditary Angioedema Therapeutic Companies Ranked by Revenue
3.3 Global Hereditary Angioedema Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Hereditary Angioedema Therapeutic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hereditary Angioedema Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hereditary Angioedema Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 Hereditary Angioedema Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 Hereditary Angioedema Therapeutic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Hereditary Angioedema Therapeutic Market Size Markets, 2021 & 2028
4.1.2 Intravenous
4.1.3 Subcutaneous
4.1.4 Oral
4.2 By Type - Global Hereditary Angioedema Therapeutic Revenue & Forecasts
4.2.1 By Type - Global Hereditary Angioedema Therapeutic Revenue, 2017-2022
4.2.2 By Type - Global Hereditary Angioedema Therapeutic Revenue, 2023-2028
4.2.3 By Type - Global Hereditary Angioedema Therapeutic Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hereditary Angioedema Therapeutic Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Hereditary Angioedema Therapeutic Revenue & Forecasts
5.2.1 By Application - Global Hereditary Angioedema Therapeutic Revenue, 2017-2022
5.2.2 By Application - Global Hereditary Angioedema Therapeutic Revenue, 2023-2028
5.2.3 By Application - Global Hereditary Angioedema Therapeutic Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Hereditary Angioedema Therapeutic Market Size, 2021 & 2028
6.2 By Region - Global Hereditary Angioedema Therapeutic Revenue & Forecasts
6.2.1 By Region - Global Hereditary Angioedema Therapeutic Revenue, 2017-2022
6.2.2 By Region - Global Hereditary Angioedema Therapeutic Revenue, 2023-2028
6.2.3 By Region - Global Hereditary Angioedema Therapeutic Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hereditary Angioedema Therapeutic Revenue, 2017-2028
6.3.2 US Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.3.3 Canada Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.3.4 Mexico Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hereditary Angioedema Therapeutic Revenue, 2017-2028
6.4.2 Germany Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.4.3 France Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.4.4 U.K. Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.4.5 Italy Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.4.6 Russia Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.4.7 Nordic Countries Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.4.8 Benelux Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hereditary Angioedema Therapeutic Revenue, 2017-2028
6.5.2 China Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.5.3 Japan Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.5.4 South Korea Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.5.5 Southeast Asia Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.5.6 India Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hereditary Angioedema Therapeutic Revenue, 2017-2028
6.6.2 Brazil Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.6.3 Argentina Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hereditary Angioedema Therapeutic Revenue, 2017-2028
6.7.2 Turkey Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.7.3 Israel Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.7.4 Saudi Arabia Hereditary Angioedema Therapeutic Market Size, 2017-2028
6.7.5 UAE Hereditary Angioedema Therapeutic Market Size, 2017-2028
7 Players Profiles
7.1 BioCryst Pharma
7.1.1 BioCryst Pharma Corporate Summary
7.1.2 BioCryst Pharma Business Overview
7.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Major Product Offerings
7.1.4 BioCryst Pharma Hereditary Angioedema Therapeutic Revenue in Global Market (2017-2022)
7.1.5 BioCryst Pharma Key News
7.2 Ionis Pharma
7.2.1 Ionis Pharma Corporate Summary
7.2.2 Ionis Pharma Business Overview
7.2.3 Ionis Pharma Hereditary Angioedema Therapeutic Major Product Offerings
7.2.4 Ionis Pharma Hereditary Angioedema Therapeutic Revenue in Global Market (2017-2022)
7.2.5 Ionis Pharma Key News
7.3 Pharming Group
7.3.1 Pharming Group Corporate Summary
7.3.2 Pharming Group Business Overview
7.3.3 Pharming Group Hereditary Angioedema Therapeutic Major Product Offerings
7.3.4 Pharming Group Hereditary Angioedema Therapeutic Revenue in Global Market (2017-2022)
7.3.5 Pharming Group Key News
7.4 CSL Limited
7.4.1 CSL Limited Corporate Summary
7.4.2 CSL Limited Business Overview
7.4.3 CSL Limited Hereditary Angioedema Therapeutic Major Product Offerings
7.4.4 CSL Limited Hereditary Angioedema Therapeutic Revenue in Global Market (2017-2022)
7.4.5 CSL Limited Key News
7.5 Shire
7.5.1 Shire Corporate Summary
7.5.2 Shire Business Overview
7.5.3 Shire Hereditary Angioedema Therapeutic Major Product Offerings
7.5.4 Shire Hereditary Angioedema Therapeutic Revenue in Global Market (2017-2022)
7.5.5 Shire Key News
7.6 Attune Pharma
7.6.1 Attune Pharma Corporate Summary
7.6.2 Attune Pharma Business Overview
7.6.3 Attune Pharma Hereditary Angioedema Therapeutic Major Product Offerings
7.6.4 Attune Pharma Hereditary Angioedema Therapeutic Revenue in Global Market (2017-2022)
7.6.5 Attune Pharma Key News
7.7 Adverum Biotechnologies
7.7.1 Adverum Biotechnologies Corporate Summary
7.7.2 Adverum Biotechnologies Business Overview
7.7.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Major Product Offerings
7.7.4 Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue in Global Market (2017-2022)
7.7.5 Adverum Biotechnologies Key News
7.8 KalVista Pharma
7.8.1 KalVista Pharma Corporate Summary
7.8.2 KalVista Pharma Business Overview
7.8.3 KalVista Pharma Hereditary Angioedema Therapeutic Major Product Offerings
7.8.4 KalVista Pharma Hereditary Angioedema Therapeutic Revenue in Global Market (2017-2022)
7.8.5 KalVista Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer